Acurx Pharmaceuticals Inc (ACXP)
1.77
-0.04
(-2.21%)
USD |
NASDAQ |
Nov 14, 12:34
Acurx Pharmaceuticals Total Liabilities (Quarterly): 3.153M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.153M |
| March 31, 2024 | 3.110M |
| December 31, 2023 | 3.042M |
| September 30, 2023 | 3.223M |
| June 30, 2023 | 3.019M |
| March 31, 2023 | 2.074M |
| December 31, 2022 | 2.062M |
| September 30, 2022 | 1.182M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.4739M |
| March 31, 2022 | 0.633M |
| December 31, 2021 | 0.8439M |
| September 30, 2021 | 0.7124M |
| June 30, 2021 | 1.919M |
| March 31, 2021 | 0.5107M |
| December 31, 2020 | 0.5224M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.4739M
Minimum
Jun 2022
3.223M
Maximum
Sep 2023
1.765M
Average
1.919M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Modular Medical Inc | 2.056M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.580M |
| Shareholders Equity (Quarterly) | 3.428M |